Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS
· Delayed Price · Currency is USD
0.2550
+0.0050 (2.00%)
Sep 26, 2025, 4:00 PM EDT
Northwest Biotherapeutics Employees
Northwest Biotherapeutics had 25 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
25
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$43,760
Profits / Employee
-$3,341,920
Market Cap
387.17M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
CytoDyn | 13 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Jushi Holdings | 1,234 |
Northwest Biotherapeutics News
- 4 weeks ago - Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. - PRNewsWire
- 5 weeks ago - Northwest Biotherapeutics Announces the Passing of Its Senior Vice President and General Counsel, Mr. Les Goldman - PRNewsWire
- 3 months ago - Northwest Biotherapeutics Announces Upcoming Presentation On Next Generation Dendritic Cells for Enhanced Anti-Tumor Treatments - PRNewsWire
- 5 months ago - Northwest Biotherapeutics: A Spike On Their Expected Imminent Approval - Seeking Alpha
- 9 months ago - Northwest Biotherapeutics announces $5M convertible note financing and standby facility for up to $50M additional financing - Seeking Alpha
- 9 months ago - Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing - PRNewsWire
- 10 months ago - Northwest Biotherapeutics: All Is Not Well With This One - Seeking Alpha
- 1 year ago - Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities - PRNewsWire